IndraLab

Statements


| 3

eidos
"Using reporter assays , we found that blocking the DUB activity by mutagenesis did not completely abrogate the ability of USP15 to inhibit the type I IFN signaling pathway ( Fig. 6 ) ."

eidos
"Inhibition of DUB activity by mutagenesis did not abrogate interferon antagonism ."

eidos
"However , inhibition of DUB activity by mutagenesis means did not completely abrogate the ability of USP25 to block viral activation of the type I IFN signaling pathway ."